Progressive fibrotic interstitial lung disease
Fibrotic lung diseases
are characterised by varying degrees of irreversible lung scarring. There is no cure and patients often experience a high burden of symptoms, including shortness of breath, cough, fatigue, depression and anxiety.
For more information on our current/recent study involvement, please follow the links to the left.
Studies & trials
-
AMBOX Study
A prospective, open-label, mixed-method, crossover randomised controlled trial, assessing the effect of oxygen on quality of life for patients with fibrotic lung disease (AmbOx). This study has been published.
-
INJUSTIS trial
It’s not Just Idiopathic pulmonary fibrosis study. A prospective study to identify biomarkers and gene expression profiles that determine progressive fibrotic in patients with fibrosing lung disease. This study is currently recruiting.
